Wednesday, 20 January 2021



              Health care and prevention

Although much of the world scientific literature is focused on the measurement of blood lactate, the non-invasive measurement of lactate in sweat and urine has a great potential in the home care of the elderly people and in the follow-up of chronic diseases. Hyperlactemia is typical of patients with severe sepsis or septic shock, it can be secondary to the anaerobic metabolism due to the hypoperfusion and it has a prognostic value. This acute condition is generally accompanied by profuse sweating. The measurement with fast response time (minutes) is mandatory even if accompanied resuscitation departments by emo gas analysis.

Lactic acidosis is found also in all diseases involving inadequate intake of oxygen to tissues (hypoxia), and that it is spy of organ failure and dysfunction: acute congestive heart failure, renal or hepatic failure, respiratory failure, severe pulmonary disease, pulmonary edema, severe anemia, diabetes not under control and a number of rare inherited metabolic and mitochondrial diseases (forms of muscular dystrophy, ALS ...). The symptoms of hypoxia requiring a lactate test are: wheezing, shortness of breath, pallor, sweating, nausea, muscle weakness, abdominal pain, coma. In all these conditions is of fundamental importance to repeat the measurement at intervals to keep under control the conditions of the patient also in response to a therapy.

The increase in lactate is not diagnostic, but it addresses the patient toward more specific clinical tests.

The size of this possible market is by far bigger than that forecasted in fitness/wellness/sport and difficult to estimate. Currently, the application of the lactate analyser in urine and saliva is a potential growth area of this project but it requires further research and development and specific certifications following EU regulation.